Nuclear Medicine and Biology
Volume 34, Issue 4 , Pages 391-397 , May 2007

Pre vivo, ex vivo and in vivo evaluations of [68Ga]-EDTMP

  • Markus Mitterhauser

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, Vienna 1090, Austria
    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Vienna 1090, Austria
    • Hospital Pharmacy, General Hospital of Vienna, Vienna 1090, Austria
    • Corresponding Author InformationCorresponding author. Department of Nuclear Medicine, AKH Wien, A-1090 Vienna, Austria. Tel.: +43 1 40400 1557; fax: +43 1 40400 1559.
  • ,
  • Stefan Toegel

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, Vienna 1090, Austria
    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Vienna 1090, Austria
  • ,
  • Wolfgang Wadsak

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, Vienna 1090, Austria
    • Department of Inorganic Chemistry, University of Vienna, Vienna 1090, Austria
  • ,
  • Rupert R. Lanzenberger

      Affiliations

    • Department of Psychiatry, Medical University of Vienna, Vienna 1090, Austria
  • ,
  • Leonhard-Key Mien

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, Vienna 1090, Austria
    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Vienna 1090, Austria
  • ,
  • Claudia Kuntner

      Affiliations

    • Department of Radiopharmaceuticals, Austrian Research Centers, Seibersdorf 2443, Austria
  • ,
  • Thomas Wanek

      Affiliations

    • Department of Radiopharmaceuticals, Austrian Research Centers, Seibersdorf 2443, Austria
  • ,
  • Harald Eidherr

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, Vienna 1090, Austria
    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Vienna 1090, Austria
  • ,
  • Dagmar E. Ettlinger

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, Vienna 1090, Austria
  • ,
  • Helmut Viernstein

      Affiliations

    • Department of Pharmaceutical Technology and Biopharmaceutics, University of Vienna, Vienna 1090, Austria
  • ,
  • Rainer Kluger

      Affiliations

    • Department of Orthopedics, Donauspital, Vienna 1220, Austria
  • ,
  • Robert Dudczak

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, Vienna 1090, Austria
  • ,
  • Kurt Kletter

      Affiliations

    • Department of Nuclear Medicine, Medical University of Vienna, Vienna 1090, Austria

Received 22 January 2007 ,Revised 23 February 2007 ,Accepted 3 March 2007.

References 

  1. Subramanian G, McAfee JG, Rosenstreich M, Coco M. Indium-113m-labeled polyfunctional phosphonates as bone-imaging agents. J Nucl Med. 1975;16:1080–1084
  2. Blau M, Nagler W, Bender MA. Fluorine-18: a new isotope for bone scanning. J Nucl Med. 1962;3:332–334
  3. Cook GJR, Fogelman I. The role of positron emission tomography in skeletal disease. Semin Nucl Med. 2001;31:50–61
  4. Langsteger W, Heinisch M, Fogelman I. Radiopharmaceuticals in bone, prostate and breast imaging. Semin Nucl Med. 2006;36:73–92
  5. Billinghurst MW. Radioion exchange in bone. In:  Billinghurst MW,  Colombetti LG editor. Studies of cellular function using radiotracers. Boca Raton (Fla): CRC Press Inc; 1982;p. 93–114
  6. Yano Y, Anger HO. A gallium-68 positron cow for medical use. J Nucl Med. 1964;5:484–487
  7. Dewanjee MK, Hnatowich DJ, Beh R. New 68Ga-labeled skeletal-imaging agents for positron scintigraphy. J Nucl Med. 1976;17:1003–1007
  8. Ehrhardt GJ, Welch MJ. A new germanium-63/gallium-68 generator. J Nucl Med. 1978;19:925–929
  9. Mitterhauser M, Tögel S, Wadsak W, Mien LK, Eidherr H, Wiesner K, et al. Binding studies of [18F]-fluoride and polyphosphonates radiolabelled with [111In], [99mTc], [153Sm] and [188Re] on bone compartments: a new model for the pre vivo evaluation of bone seekers?. Bone. 2004;34:835–844
  10. Mitterhauser M, Toegel S, Wadsak W, Mien LK, Eidherr H, Kletter K, et al. Binding studies of [18F]-fluoride and polyphosphonates radiolabelled with [90Y], [99mTc], [111In], [153Sm] and [188Re] on bone compartments: verification of the pre vivo model?. Bone. 2005;37:404–412
  11. Toegel S, Mien L-K, Wadsak W, Eidherr H, Viernstein H, Kluger R, et al. In-vitro evaluation of nca., ca. and cross-complexed [90Y]-EDTMP provides evidence for a novel “foreign carrier theory”. Nucl Med Biol. 2006;33:95–99
  12. Li WP, Ma DS, Higginbotham C, Hoffman T, Ketring AR, Cutler CS, et al. Development of an in vitro model for assessing the in vivo stability of lanthanide chelates. Nucl Med Biol. 2001;28:145–154
  13. Tai YC, Ruangma A, Rowland D, Siegel S, Newport DF, Chow PL, et al. Performance evaluation of the microPET Focus: a third generation microPET scanner dedicated to animal imaging. J Nucl Med. 2005;46:455–463
  14. Mentzel HJ, Kentouche K, Sauner D, Fleischmann C, Vogt S, Gottschild D, et al. Comparison of whole-body STIR-MRI and 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions. Eur Radiol. 2004;14:2297–2302
  15. Eustace S, Tello R, DeCarvalho V, Carey J, Wroblicka JT, Melhem ER, et al. A comparison of whole-body turboSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol. 1997;169:1655–1661
  16. Gaa J, Rummeny EJ, Seemann MD. Whole-body imaging with PET/MRI. Eur J Med Res. 2004;9:309–312
  17. Toegel S, Hoffmann O, Wadsak W, Ettlinger D, Mien LK, Wiesner K, et al. Uptake of bone seekers is solely associated with mineralisation! A study with [99mTc]-MDP, [153Sm]-EDTMP and [18F]-fluoride on osteoblasts. Eur J Nucl Med Mol Imaging. 2006;33:491–494
  18. Yang DJ, Kim EE, Inoue T. Targeted molecular imaging in oncology. Ann Nucl Med. 2006;20:1–11

PII: S0969-8051(07)00076-5

doi: 10.1016/j.nucmedbio.2007.03.002

Nuclear Medicine and Biology
Volume 34, Issue 4 , Pages 391-397 , May 2007